Found 7 matching trials
Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell Carcinoma PHASE2 The TORAVA trial is designed to evaluate the progression-free rate at 48 we...
Show More Location
Centre Paul Papin
Learn More & Join Trial
Bevacizumab, Dacarbazine and Interferon-Alfa to Treat Metastatic Melanoma PHASE2 The purpose of this study is to determine whether combination therapy with ...
Show More Location
Kuopio University Hospital
Learn More & Join Trial
A Study of Avastin (Bevacizumab) in Combination With Low-Dose-Interferon in Patients With Metastatic Clear Cell Renal Cell Carcinoma (RCC). PHASE2 This single arm study will assess progression free survival, tumor response...
Show More Location
Multiple Locations
Learn More & Join Trial
Sequential Therapy in Metastatic Renal Cell Carinoma PHASE2 Sequential therapy with BEvacizumab, RAd001 (everolimus) and Tyrosinekinase...
Show More Learn More & Join Trial
Bevacizumab in Metastatic Renal Cancer N/A This is a non-interventional, multicenter study to evaluate efficacy and sa...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer. PHASE2 This single arm study will assess the efficacy and safety of Avastin in com...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors PHASE1 This global, multicenter, open-label study will evaluate the safety and tol...
Show More Location
HonorHealth Research Institute - Bisgrove
Learn More & Join Trial